Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in operable breast cancer patients with hormone receptor-positive, HER2-negative - Quiz - MDSpire

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in operable breast cancer patients with hormone receptor-positive, HER2-negative

  • By

  • Yirui Wei

  • Mengyuan Wang

  • Yong Huang

  • Lu Gan

  • Kangjie Li

  • Yifeng Li

  • Zhaoyang Li

  • Qiao Cheng

  • May 8, 2026

  • 0 min

Share

Original Source(s)

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in operable breast cancer patients with hormone receptor-positive, HER2-negative

  • by Yirui Wei, Mengyuan Wang, Yong Huang, Lu Gan, Kangjie Li, Yifeng Li, Zhaoyang Li, Qiao Cheng

  • May 8, 2026

Related Content

Effects of SOX10 on the proliferative, invasive, migratory, and epithelial–mesenchymal transition abilities of triple-negative breast cancer cells

Combined reconstruction of complex chest wall defects using mesh-supported rigid materials and abdominal flap strategies: a retrospective clinical study

Diagnosis and treatment of breast cancer metastasis to thyroid: a case report and literature review